Mark For: ONCOTYPE DXI™ trademark registration is intended to cover the categories of
Research | OneLook Acronym Finder |
Serial Number | 88126037 |
Mark Literal Elements | ONCOTYPE DXI |
Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
Mark Type | TRADEMARK. SERVICE MARK |
Register | PRINCIPAL |
Current Location | TMO LAW OFFICE 118- EXAMINING ATTORNEY ASSIGNED 2019-11-13 |
Basis | 1(b) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | No |
Current Use | No |
Intent To Use | Yes |
Filed ITU | Yes |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Attorney Name | Margaret C. McHugh |
Attorney Docket Number | 1085196 |
Law Office Assigned | M90 |
Employee Name | HUSSAIN, TASNEEM |
2018-09-20 | Application Filed |
2019-01-03 | Location: TMO LAW OFFICE 118- EXAMINING ATTORNEY ASSIGNED |
2019-01-03 | Status: Live/Pending |
2019-01-03 | Transaction Date |
2019-11-13 | Location: TMO LAW OFFICE 118- EXAMINING ATTORNEY ASSIGNED |
2019-11-13 | Status: Abandoned because the applicant failed to respond or filed a late response to an Office action. To view all documents in this fi |
Party: | Genomic Health, Inc. |
Address | 301 Penobscot Drive Redwood City, CALIFORNIA UNITED STATES 94063 |
Legal Entity Type | Corporation |
Legal Entity State | DELAWARE |
Drawing | IMAGE/JPEG | 2018-09-20 |
TEAS RF New Application | APPLICATION/XML,IMAGE/JPEG | 2018-09-20 |
XSearch Search Summary | XML | 2019-01-02 |
Offc Action Outgoing | MULTI | 2019-01-03 |
TEAS Rev, App and/or COA of Atty/Dom.Rep | XML | 2019-03-07 |
Response to Office Action | MULTI | 2019-04-03 |
Amendment and Mail Process Complete | APPLICATION/XML,IMAGE/JPEG | 2019-04-10 |
Offc Action Outgoing | MULTI | 2019-04-16 |
Notice of Abandonment | XML | 2019-11-13 |
(ABANDONED)
IC 001. US 001 005 006 010 026 046. G & S: assays for testing tissue samples for use in cancer detection, analysis and prognosis; kits consisting primarily of enzymes for scientific and research purposes, nucleic acids, buffers, reagents and assays for use in disease testing; reagents for scientific or medical research use, namely, reagents for use in preparation of RNA samples(ABANDONED)
IC 005. US 006 018 044 046 051 052. G & S: kits comprised of medical reagents and assays for testing tissue samples for use in cancer detection, analysis and prognosis; medical reagents; kits consisting primarily of enzymes for medical purposes, nucleic acids, buffers, reagents and assays for use in disease testing; medical assays for testing of bodily fluids for use in disease detection, namely, cancer for medical and prognostic purposes; medical reagents and assays for testing tissue samples for use in disease detection, namely, cancer; enzyme preparations for medical purposes; biological preparations for the detection and monitoring of cancer; preparations for detecting genetic predispositions for medical purposes; biological preparations for use in the analysis and prognosis of cancer(ABANDONED)
IC 042. US 100 101. G & S: Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing medical testing services and information in the field of cancer research and disease classification(ABANDONED)
IC 044. US 100 101. G & S: Medical testing for prognostic purposes in the field of cancer and disease classification; providing medical information to medical professionals in the form of reports in the field of cancer and disease classification
International Codes: | 1 |
U.S. Codes: | 001,005,006,010,026,046 |
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
International Codes: | 42 |
U.S. Codes: | 100,101 |
International Codes: | 44 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
GS0441 | Medical testing for diagnostic and prognostic purposes in the field of cancer and disease classification; providing medical information to medical professionals in the form of reports in the field of cancer and disease classification |
Description | Date | Proceeding Number |
---|---|---|
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | 2019-11-13 | |
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | 2019-11-13 | |
NOTIFICATION OF FINAL REFUSAL EMAILED | 2019-04-16 | |
FINAL REFUSAL WRITTEN | 2019-04-16 | 81112 |
FINAL REFUSAL E-MAILED | 2019-04-16 | |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2019-04-09 | 70633 |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2019-04-09 | 70633 |
ASSIGNED TO LIE | 2019-04-08 | 70633 |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2019-04-03 | |
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2019-03-07 | |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2019-03-07 | |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2019-01-03 | 6325 |
NON-FINAL ACTION WRITTEN | 2019-01-03 | 81112 |
NON-FINAL ACTION E-MAILED | 2019-01-03 | 6325 |
ASSIGNED TO EXAMINER | 2019-01-02 | 81112 |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2018-09-27 | |
NEW APPLICATION ENTERED IN TRAM | 2018-09-24 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.